2019
Why Cities and Health?
Ettman C, Vlahov D, Galea S. Why Cities and Health? 2019, 15-24. DOI: 10.1093/oso/9780190915858.003.0002.Peer-Reviewed Original Research
2005
Drug use, misuse, and the urban environment
GALEA S, RUDENSTINE S, VLAHOV D. Drug use, misuse, and the urban environment. Drug And Alcohol Review 2005, 24: 127-136. PMID: 16076582, DOI: 10.1080/09595230500102509.Peer-Reviewed Original Research
2000
HIV testing and retesting for men and women in Switzerland
Zwahlen M, Neuenschwander B, Jeannin A, Dubois-Arber F, Vlahov D. HIV testing and retesting for men and women in Switzerland. European Journal Of Epidemiology 2000, 16: 123-133. PMID: 10845261, DOI: 10.1023/a:1007638823567.Peer-Reviewed Original Research
1994
HIV vaccines for injection drug users in the context of a comprehensive prevention agenda.
Vlahov D. HIV vaccines for injection drug users in the context of a comprehensive prevention agenda. AIDS Research And Human Retroviruses 1994, 10 Suppl 2: s3-6. PMID: 7865324.Peer-Reviewed Original ResearchConceptsHIV infectionHIV vaccineDrug usersHuman immunodeficiency virus (HIV) infectionImmunodeficiency virus infectionEffective HIV vaccineInjection drug usersMajor health problemNeedle exchange programsHigh-risk behaviorsParenteral transmissionVirus infectionHealth problemsDrug abusePrevention agendaInfectionRisk reductionVaccineHIVPopulationAbstinenceExchange programs
1993
Bacterial Pneumonia in Adult Populations with Human Immunodeficiency Virus (HIV) Infection
Caiaffa W, Graham N, Vlahov D. Bacterial Pneumonia in Adult Populations with Human Immunodeficiency Virus (HIV) Infection. American Journal Of Epidemiology 1993, 138: 909-922. PMID: 8256779, DOI: 10.1093/oxfordjournals.aje.a116812.Peer-Reviewed Original ResearchConceptsBacterial pneumoniaRisk factorsHuman immunodeficiency virus (HIV) infectionEffectiveness of chemoprophylaxisImmunodeficiency virus infectionRecurrent bacterial pneumoniaHuman immunodeficiency virusEfficacy of interventionsPneumonia ratesImmunodeficiency syndromeImmunodeficiency virusClinical trialsVaccine interventionsVirus infectionEpidemiologic studiesClinical practicePneumoniaAdult populationDiagnostic algorithmFuture interventionsInterventionHIVSuch interventionsPopulationChemoprophylaxis